Regenerative Medicines Market: Global Market Size, Trends, Competitive, Historical and
Forecast Analysis, 2020– 2030. Increased adoption of regenerative medicine, technological
advancement, shortage of organs for transplantation with involvement of stem cells are
expected to drive the regenerative medicine market growth.
The global regenerative medicine market is expected to reach USD 172.17 billion by 2030
from USD 13.22 billion in 2019, at a CAGR of 26.2%.
Increased pipeline of regenerative medicines along with growing government investments
are likely to drive the overall regenerative medicine market growth. Also, rising demand for
organ transplantation and increasing awareness about the use of regenerative medicinal
therapies in organ transplantation along with implementation of the 21st Century Cures Act,
a U.S. law enacted by the 114th United States Congress in December 2016 are creating
growth opportunities in the market. However, high cost of treatment and stringent
government regulations are expected to hinder the market growth.
Access Full Description of this report at:-
Top Companies: Integra Lifesciences Corporation, AbbVie Inc., Merck KGaA, Medtronic,
Thermo Fisher Scientific Inc., Smith+Nephew, Becton, Dickinson and Company, Baxter
International Inc, Cook Biotech, and Organogenesis Inc and others.
Based on product type, the market is segmented into cell therapy, gene therapy, tissue
engineering, and small molecules & biologics. Based on material, the market is divided into
synthetic material, biologically derived material, genetically engineered material, and
pharmaceutical. By application, it is categorized into cardiovascular, oncology, dermatology,
musculoskeletal, wound healing, ophthalmology, neurology, and others. Geographically, it is
analyzed across four regions, i.e., North America, Europe, Asia-Pacific, and RoW.
Request sample copy of this report at:-